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Neurturin regulates the lung-resident macrophage
inflammatory response to viral infection
Emma Connolly1,2 , David J Morgan1,2, Miriam Franklin1,2, Angela Simpson3, Rajesh Shah4, Oliver J Brand1,2,
Christopher P Jagger1,2, Joshua Casulli1,2, Karishma Mohamed1,2, Aleksander M Grabiec2 , Tracy Hussell1,2
Lung-resident macrophages are crucial to the maintenance of
health and in the defence against lower respiratory tract infec-
tions. Macrophages adapt to local environmental cues that drive
their appropriate function; however, this is often dysregulated in
many inflammatory lung pathologies. In mucosal tissues, neuro-
immune interactions enable quick and efficient inflammatory
responses to pathogenic threats. Although a number of factors
that influence the antimicrobial response of lung macrophages
are known, the role of neuronal factors is less well understood.
Here, we show an intricate circuit involving the neurotrophic
factor, neurturin (NRTN) on human lungmacrophages that dampens
pro-inflammatory cytokine release and modulates the type
of matrix metalloproteinases produced in response to viral
stimuli. This circuit involves type 1 interferon–induced up-regulation
of RET that when combined with the glial cell line-derived neu-
rotrophic factor (GDNF) receptor α2 (GFRα2) allows binding to
epithelial-derived NRTN. Our research highlights a non-neuronal
immunomodulatory role for NRTN and a novel process leading to
a specific antimicrobial immune response by human lung-resident
macrophages.
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Introduction
Lower respiratory tract infections and chronic respiratory diseases
are within the top four causes of mortality globally (Barnes, 2019).
Therefore, understanding the inflammatory cascades involved in
the pathogenesis of these diseases is critical in developing new
therapeutics and alleviating the clinical burden. Because of their
location in the airways, lung-resident alveolar macrophages are in
direct contact with the external environment and are at the first line
of defence against infectious agents. For this reason, macrophage
function needs to be tightly regulated to maintain homeostasis
through tolerance to cellular debris and innocuous antigens, while
still mounting an effective immune response against harmful
pathogens and limiting bystander tissue damage (Hussell & Bell,
2014). Upon host infection with a virus, lungmacrophages produce a
range of cytokines, including type I IFNs, IL-6, and IL-12, in response
to TLR activation (Yan & Chen, 2012; Goritzka et al, 2015). Type I IFNs,
in turn, trigger the JAK—signal transducers and activators of tran-
scription (STAT) pathway, which leads to the activation of a large
number of interferon stimulated genes (Ivashkiv & Donlin, 2014).
These genes encode proteins that induce cell-intrinsic anti-viral
defences, but also cytokines and chemokines that are critical in
the immune response to clear the threat (Rauch et al, 2013; Rusinova
et al, 2013). However, the specific interferon-stimulated genes in-
duced in macrophages by a given pathogen or TLR receptor and how
this directs the ensuing inflammatory cascade, especially in humans,
is largely unknown.
Mucosal sites, including the lung, are highly innervated with
peripheral nerves and growing evidence implicates neuro-immune
interactions in health and disease in the gastrointestinal tract
(Chesne et al, 2019). Conversely, how neuronal signals affect im-
mune cell function in the lung is less well established. RET is a
receptor tyrosine kinase that is activated by glial cell line–derived
neurotrophic factor (GDNF) family receptors and their ligands
(GFLs). GDNF binds to GDNF family receptor (GFR)α1, neurturin
(NRTN) to GFRα2, artemin to GFRα3, and persephin to GFRα4
(Airaksinen & Saarma, 2002). Ligand binding to the receptor promotes
dimerization of RET and subsequent changes in biological processes
such as differentiation, proliferation, and apoptosis (Lemmon &
Schlessinger, 2010), predominantly characterised in the nervous
system. RET is essential for the development of the enteric nervous
system (Schuchardt et al, 1994) and, through the formation of a
GFRα3/Artemin/RET signalling complex, governs the formation of
enteric Peyer’s patches (Veiga-Fernandes et al, 2007). However, the
GDNF family also have non-neuronal immune-modulatory functions
in the gastrointestinal tract. In this setting, TLR agonists or alarmins
stimulate enteric glial cells to produce the ligands, GDNF, and NRTN
(Ibiza et al, 2016). This in turn leads to the activation of RET-expressing
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group 3 innate lymphoid cells (ILC3s) and subsequent production of
IL-22 in a STAT3-dependent manner (Ibiza et al, 2016). IL-22 then acts
on gut epithelial cells to drive antimicrobial responses, therefore
implicating the GDNF family in promoting host defence against in-
fection (Ibiza et al, 2016).
Evidence also implicates the GDNF family in other diverse as-
pects of the immune system. NRTN exhibits anti-inflammatory
properties by inhibiting the secretion of IL-6 and TNFα from LPS-
stimulated human PBMCs (Vargas-Leal et al, 2005) and dampens
the inflammatory response to allergens in a mouse model of
asthma (Mauffray et al, 2015). Within the bone marrow, RET sig-
nalling promotes haematopoietic stem cell survival and function
(Fonseca-Pereira et al, 2014) and regulates their daily migration into
the circulation (Garcia–Garcia et al, 2019). Meanwhile GFRα2 has
been defined as a marker for the human intermediate monocyte
subset (Wong et al, 2011) and B cell progenitors (Jensen et al, 2018).
Therefore, this accumulating data clearly shows that GDNF family
members play significant roles in shaping immune responses.
We hypothesised that receptors classically attributed to neu-
ronal cells would be expressed by lung macrophages and drive
their function. We searched for neuronal receptors on human lung-
resident macrophages and found a specific sequence of steps
leading to formation of a GFRα2-RET-NRTN complex that was
amplified in lung macrophages from chronic smokers and tumour
tissue. We determined that viral infection, or mimics thereof,
specifically enhanced the production of the GFRα2 ligand, NRTN,
from lung epithelium, whereas type I IFNs induced expression of the
signalling receptor RET in lung macrophages. RET activation led to a
reduction in pro-inflammatory cytokine release and a switch in the
type of matrix metalloproteinases (MMPs) produced from macro-
phages. This highly specific outcome following the precise devel-
opment of a multi-component receptor highlights an important,
non-neuronal role for GFRα2 in directing macrophage function to
promote host defence.
Results
Human lung macrophages constitutively express GFRα2 and the
signalling co-receptor RET is induced by TLR activation
Though neuronal factors have been predominantly characterised
in the nervous system, we observed high GFRα2 expression under
conditions of GM-CSF, compared with M-CSF, differentiation of
murine BMDMs by RT2 profiler array (Fig S1A and B) and confirmed
this by quantitative (q)PCR (Fig S1C and D). GMCSF plays a significant
role in lung immune homeostasis and is critical in the development
of alveolar macrophages (Schneider et al, 2014). Consistent with in
vitro data, GFRα2 was highly expressed on mouse (Fig S1E) and
human lung macrophages, compared with other members of the
GDNF family, at the mRNA level (Fig 1A). GFRα2 was also expressed
on human peripheral blood monocytes and human monocyte-
derived macrophages (MDMs) (Fig 1B). On the other hand, the
co-receptor, RET, could not be detected in monocytes, human
MDMs or human lung macrophages (MΦs) at steady state (Fig 1A
and B). GFRα2 and RET expression was further confirmed at the
protein level, with GFRα2 expression observed in human lung
macrophages and human MDMs (Fig 1C and D), whereas the co-
receptor RET was only detected in PMA-treated THP-1 macrophages
(Fig 1D). To determine the trigger for macrophage expression of RET;
human MDMs were stimulated with Th1/Th2 cytokines and TLR
agonists. Cytokines associated with polarising macrophages had
little effect on RET expression (Fig 1E); however, RET mRNA ex-
pression was significantly induced by the TLR3 agonist, polyI:C, and
to a lesser extent by the TLR4 and TLR7/8 agonists, LPS and R848,
respectively (Fig 1E). Therefore, although macrophages constitu-
tively express GFRα2, the signalling component, RET, is induced by
stimuli associated with viral infection.
Lung epithelial cells express the GDNF family ligand NRTN
We next determined that one possible source of the GFRα2 ligand
was airway epithelial cells, where NRTN was detected under basal
conditions at the mRNA (Fig 1F) and protein (Fig 1G) level in the A549
cell line. This was confirmed in the bronchial epithelial cell line
BEAS-2B (Fig S2A). Interestingly, the dominant GFRα receptor in
epithelial cells is GFRα1 (Figs 1F and S2B). Enhanced production of
NRTN was observed in A549 cells after stimulation with polyI:C and
LPS (Fig 1G). Furthermore, increased NRTN was detected in the BAL
fluid of influenza infected mice at time points associated with peak
inflammation (Fig S2C). This data further supports a role for the
GFRα2–RET–NRTN complex in host defence by lung macrophages.
Moreover, GFRα2 expression by monocytes and macrophages sug-
gests that this is not tissue specific or associated with a particular
monocyte/macrophage lineage.
Macrophage RET expression is indirectly induced by TLR agonists
via type I IFNs
The TLR3 receptor agonist polyI:C triggers a downstream signalling
cascade involving TANK-binding kinase 1 (TBK1) that induces the
production of type I IFNs (Clark et al, 2011). In human MDMs, polyI:C
enhanced IFNα and IFNβ mRNA (Fig S3A and B, respectively).
However, in human lung macrophages, polyI:C significantly up-
regulated the protein release (Fig 2A) and mRNA of IFNβ (Fig 2B),
but not IFNα (Fig S3C). Blockade of TBK1 activation with BX795
abolished polyI:C-induced up-regulation of IFNβ (Fig 2A and B) and
RET mRNA by human lung macrophages (Fig 2C). To determine
whether RET is induced directly or indirectly by TLR3 activation,
human lung macrophages (Fig 2D), human peripheral blood
monocytes (Fig 2E) and human MDMs (Fig 2F) were stimulated with
IFNs (IFNα, IFNβ, IFNγ, and IFNλ). RET expression was up-regulated
by IFNβ in all three cell types at the mRNA level (Fig 2D–F). Fur-
thermore, a slight increase in GFRα2 expression was observed in
human lung macrophages by IFNγ (Fig S3D). The mRNA for the most
common RET isoforms, RET 9 and RET 51, were both up-regulated by
IFNβ, and to a lesser extent IFNα stimulation, in human lung
macrophages (Fig S3E). This RET up-regulation was confirmed at the
protein level in humanMDMs using different concentrations of IFNβ
(Fig 2G and H). GFRα2 protein, however, remained unchanged (Fig
2I). Although THP-1 monocytes and PMA-treated THP-1 macro-
phages expressed RET constitutively (Figs S3F and 1D, respectively),
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IFNβ further enhanced RET protein in PMA-treated THP-1 macro-
phages (Fig 2J).
NRTN up-regulates MMP2 production by human lung
macrophages
To determine the function of NRTN on human lung macrophages,
we ran a qPCR array analysis for genes related to macrophage
function. In the case for macrophages from this donor, NRTN alone
had mild effects on macrophages, including the up-regulation of
neuropeptide Y receptor type 2 (NPY2R) but down-regulation of
NPY1R (Fig S4A). This mild effect of NRTN likely reflects that RET
expression has not been induced and so we next examined the
effect of NRTN on IFNβ-stimulated human lung macrophages. IFNβ
alone increased mRNA for the granulocyte chemoattractant, CXCL8
and the lymphocyte chemoattractant, CXCL9 (Fig S4B). However,
IFNβ stimulation of human lung macrophages with the addition of
NRTN enhanced MMP2 mRNA and down-regulated IL-6, IFNy, MAPK,
MMP9, and IL-12A compared with IFNβ alone (Fig S4C). Gain-of-
function mutations in RET lead to the development of specific
Figure 1. Human lung macrophages express GFRα2
and induce RET expression after TLR activation,
whereas lung epithelial cells express the ligand
NRTN.
(A) Relative mRNA expression (2−ΔCT × 104) of GDNF
family receptors and ligands in human lung
macrophages (n = 3). (B) Relative mRNA expression of
GFRα2, RET, and NRTN in peripheral bloodmonocytes
(n = 3) or MDMs (n = 6) from non-matched donors.
(C) Representative images of GFRα2 expression in human
lung macrophages by immunofluorescence (GFRα2
or isotype control [red] DAPI [blue]). Scale bar = 20 μM.
(D) Representative Western blot of GFRα2 and RET
protein expression in MDMs (lanes 1–3) (n = 3), human
lung macrophages (MΦs) (lanes 4–6) (n = 3) and PMA-
treated THP-1 macrophage positive control (lane 7);
β-actin housekeeping control. (E)mRNA expression of
RET inMDMsafter stimulationwith IL-4, IL-10, IL-13 (all 20
ng/ml), polyI:C (10 μg/ml), LPS, or R848 (both 100 ng/ml)
for 24 h (n = 3) expressed as a fold change over the
average expression of untreated (UT) cells. (F) Relative
mRNA expression (2−ΔCT × 104) of GDNF family receptors
and ligands in A549 cells (n = 3). (G) ELISA analysis of
NRTN in A549 cells stimulated with polyI:C (10 μg/ml),
LPS, R848 (both 100 ng/ml), IFNα or IFNβ (both 20
ng/ml) for 24 h (n = 3). Data information: Data are
shown as mean ± SEM from three to six
independent experiments. (E, G) *P < 0.05, **P < 0.01,
***P < 0.001; one-way ANOVA with Tukey’s post
hoc test with multiple comparisons (E, G).
Source data are available for this figure.
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human cancers and have been associated with the regulation of
MMPs, including MMP2 and MMP9, which are thought to drive
metastasis (Kato et al, 1998; Asai et al, 1999). To validate the effect of
NRTN on MMP2 production, human lung macrophages were stim-
ulated with polyI:C or IFNβ, with or without NRTN. PolyI:C-stimulated
human lung macrophages, with the addition of NRTN, significantly
enhanced the production of MMP2 (~140 kD, homodimer) (Fig 3A and
B). In contrast to the changes in MMP2 at the mRNA level, NRTN did
not enhance MMP2 production in IFNβ-stimulated human lung
macrophages (Fig 3B). The expression of MMP9 was also analysed as
this MMP belongs to the same group as MMP2, the gelatinases;
however, MMP9 (~92 kD) was unchanged by NRTN stimulation (Fig
Figure 2. Macrophage RET expression is indirectly stimulated by TLR agonists via type I IFNs.
(A, B, C) ELISA analysis of IFNβ release (n = 3) (A) and mRNA expression of IFNβ (B) or RET (C) (n = 6) in human lung macrophages stimulated with polyI:C (10 μg/ml) ±
BX795 (5 μg/ml) for 24 h. (D, E, F) RET mRNA expression in human lung macrophages (D), human peripheral blood monocytes (E), and human MDMs (F) stimulated with
IFNα, IFNβ, IFNγ, or IFNλ (all at 20 ng/ml) for 24 h (n = 3). (G, H, I) Representative Western blot (untreated [lane 1], 20 ng/ml IFNβ [lane 2], 100 ng/ml IFNβ [lane 3]) (G) and
densitometry analysis of RET (H) and GFRα2 (I) protein expression relative to β-actin in human MDMs stimulated with 20 ng/ml or 100 ng/ml of IFNβ for 24 h (n = 3). (J)
Representative images of RET expression in untreated or IFNβ-treated PMA-treated THP-1 macrophages (top panels; untreated [UT], bottom panels; IFNβ-treated [20 ng/
ml], RET [red] DAPI [blue]). Scale bar = 40 μM. Data information: Data are shown as mean ± SEM from three to six independent experiments. (A, C, D, E, F, H) *P < 0.05, **P <
0.01, ***P < 0.001; one-way ANOVA with Tukey’s post hoc test with multiple comparisons (A, D, E, F, H); Kruskal–Wallis test with Dunn’s multiple comparisons test (C).
Source data are available for this figure.
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Figure 3. NRTN promotes MMP2 and MMP9 production from macrophages.
(A, B) RepresentativeWestern blot (A) and densitometry analysis (B) of MMP2 in human lungmacrophages treated with polyI:C (10 μg/ml) or IFNβ (20 ng/ml) ± NRTN (100
ng/ml) for 24 h (n = 3). (C, D, E) Representative Western blot (C) and densitometry analysis of MMP2 (D) or MMP9 (E) protein expression in PMA-treated THP-1 macrophages
stimulated with AD80 (0.5 μM) ± NRTN (100 ng/ml) for 24 h (n = 4). Densitometry analysis of MMP2 and MMP9 is expressed relative to β-actin. (F, G) Representative image (F)
and quantification per cell and per cell area (G) of gelatin degradation by human lung macrophages stimulated with polyI:C (10 μg/ml) ± NRTN (100 ng/ml) for 24 h (n = 3).
Eachdot on the graph represents afield of view,minimumseven fieldsof viewper donor. Scale bar = 50μM.Data information: Data are shownasmean ± SEM from threeor four
independent experiments. (B, D, E, G) *P < 0.05, **P < 0.01, ***P < 0.001; Student’s paired two-tailed t test (B, D, E, G).
Source data are available for this figure.
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S4D and E). Interestingly, IFNβ significantly reduced MMP9 protein
release from lung macrophages (Fig S4F), although this was not
observed at the mRNA level (Fig S4B).
To determine whether inhibition of RET leads to the down-regulation
ofMMP2 production inmacrophages, the RET inhibitor, AD80, was used in
PMA-treated THP-1 macrophages. A reduction in MMP2 (~72 kD) and
MMP9 (~92kD)production following treatmentwithAD80wasobserved in
both the presence and absence of NRTN (Fig 3C–E). To investigate
whether the changes in MMP2 production induced by NRTN in polyI:C-
stimulated macrophages had a functional effect on MMP2 activity we
performed a gelatin degradation assay. A reduction in MMP activity from
polyI:C and NRTN stimulated human lungmacrophages was observed as
measured by their reduced ability to degrade gelatin when analysed per
numberof cells or by cell area, comparedwithpolyI:C alone (Fig 3F andG).
This reduction in gelatin degradation did not correlate with the increase
in MMP2 production observed and suggests that NRTN via RET ligation
may either negatively affect MMP2 activity or regulate the production of
other MMPs that can degrade gelatin.
NRTN down-regulates MMP1 and MMP3 production by
macrophages
TodeterminewhetherNRTNcan regulate theproductionofother typesof
MMPs by human lung macrophages, the production of the interstitial
collagenase, MMP1, and the stromelysin, MMP3, was analysed. The
production of MMP1 and MMP3 has been previously linked to RET ac-
tivation (Mesa et al, 2006; Kang et al, 2009) and gelatin is a known
substrate for both of these MMPs. PolyI:C-stimulated human lung
macrophages, with the addition of NRTN, down-regulated the production
of MMP3 (~20 kD form) compared with polyI:C alone (Fig 4A and B). MMP1
was not expressed by human lung macrophages (data not shown).
Conversely RET inhibitionbyAD80, in thepresenceor absenceofNRTN, in
PMA-treated THP-1 macrophages increased the expression of MMP1 (~53
kD) and MMP3 (~54 kD) (Fig 4C–E). Overall, these data show that RET
activation via Gfrα2 and NRTN decreases the production of MMP3 and
promotes MMP2 in primary human lung macrophages but MMP activity
may also be affected. Our data suggest that RET could switch the
Figure 4. NRTN reduces MMP1 and MMP3 production from macrophages.
(A, B)RepresentativeWestern blot (A) and densitometry analysis of MMP3 (B) in human lungmacrophages stimulatedwith polyI:C (10μg/ml) ± NRTN (100 ng/ml) for 24 h (n = 3). (C, D, E)
RepresentativeWestern blot (C) and densitometry analysis ofMMP1 (D) orMMP3 (E) protein expression in PMA-treated THP-1macrophages stimulatedwith AD80 (0.5 μM) ± NRTN (100 ng/
ml) for 24h (n= 3–7). Densitometry analysis ofMMP1andMMP3 is expressed relative toβ-actin. Data information: Dataare shownasmean±SEM fromthree independentexperiments. (B, D,
E) *P < 0.05; Student’s paired two-tailed t test (B, D, E).
Source data are available for this figure.
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production of MMPs produced by macrophages depending on the de-
mands of the tissue at that time.
NRTN dampens the release of pro-inflammatory cytokines from
human lung macrophages
The GDNF family is a member of the wider TGFβ superfamily and as
such have been hypothesised to have anti-inflammatory properties.
In our system, NRTN significantly decreased the release of IL-6 (Fig
5A) and IL-12p40 (Fig 5B), but not TNFα (Fig 5C) or IL-10 (Fig 5D), from
polyI:C-stimulated human lung macrophages. This suggests that
NRTN may prevent excessive inflammation and limit further tissue
damage during a viral infection. The data also corroborate an anti-
inflammatory role for the GDNF family.
GDNF family expression is enhanced in macrophages from the
lungs of chronic smokers and tumour tissue
MMPs are implicated in a range of chronic airway diseases, such as
asthma, chronic obstructive pulmonary disease (COPD) (Hendrix &
Kheradmand, 2017), and cancer metastases (Kessenbrock et al, 2010).
GFRα2, RET, and MMP2 mRNA expression was analysed in lung mac-
rophages from patients with COPD compared with patients with no
underlying respiratory disease (Fig 6A–C). No significant differences
could be identified. However, if patients were categorised based on
their smoking status, a significant increase in GFRα2 and MMP2 mRNA
was detected in lung macrophages from current smokers compared
with non-smokers, regardless of disease status (Fig 6D–F). A recent
genome-wide association study study found that RET expression is
linked to the number of cigarettes smoked per day (Matoba et al, 2019);
however, we did not see enhanced RET mRNA expression in lung
macrophages from smokers compared with non-smokers in our
smaller study group (Fig 6E). GFRα2 and RETmRNA was also compared
between macrophages isolated from lung tumours and surrounding
healthy margin tissue. Although no difference was detected in GFRα2
mRNA (Fig 6G), RET mRNA was increased in tumour compared with
marginmacrophages (Fig 6H). These data suggest that the GDNF family
may be important factors to investigate further in the context of
smoking/COPD and lung cancer, with regard to their effect on MMP
production.
Discussion
Our data demonstrate that NRTN drives a functional switch in
human lung-resident macrophages that inhibits inflammatory
cytokine production and controls the expression of MMPs (Fig 7).
That Gfrα2 was expressed on monocytes and macrophages irre-
spective of their stage of differentiation, tissue location, or subtype,
which suggests a fundamental role in macrophage biology. Reg-
ulation of MMP production via this pathway relies on viral triggers to
promote NRTN production from epithelial cells and type I IFN to up-
regulate the signalling adapter RET in macrophages. Collectively,
the data imply an important role for this multi-component receptor
in airway host defence.
Accumulating evidence describes a role for the GDNF family in
shaping an antimicrobial immune response. Intestinal ILC3s are
critical regulators of host defence (Artis & Spits, 2015) that con-
stitutively express RET and respond to neurotrophic factors se-
creted by glial cells (Ibiza et al, 2016). In this case, the outcome is IL-
22 release that in turn initiates repair genes in epithelial cells and
promotes host defence. The induction of RET by type I IFNs that we
Figure 5. NRTN dampens the release of pro-
inflammatory cytokines from human lung
macrophages.
(A, B, C, D) ELISA analysis of IL-6 (A), IL-12p40 (B), TNFα
(C) and IL-10 (D) release from human lung
macrophages stimulated with polyI:C (10 μg/ml) or
IFNβ (20 ng/ml) ± NRTN (100 ng/ml) for 24 h (n = 4). Data
information: Data are shown as mean ± SEM from
four independent experiments. (A, B) *P < 0.05, ***P <
0.001; one-way ANOVA with Tukey’s post hoc test with
multiple comparisons (A, B).
Source data are available for this figure.
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observe in macrophages implicates the GDNF family in mediating
host defence in the respiratory tract. We show that RET activation in
human lung macrophages by NRTN alters the production of MMPs
by enhancing MMP2 and reducing MMP3 production. We also ob-
serve that RET inhibition in THP-1 macrophages decreases the
production of MMP2 and MMP9 and enhances the production of
MMP1 andMMP3. RET activationmay therefore provide a critical hub
for the control of macrophage MMP production. The MMPs are a
family of zinc-dependent endopeptidases and have various im-
portant functions in infection, disease, repair and lung develop-
ment (Beeh et al, 2003; Belvisi & Bottomley, 2003; Hendrix &
Kheradmand, 2017). MMPs are expressed at relatively low levels
at homeostasis but are up-regulated during inflammation and their
production must be tightly controlled (Loffek et al, 2011). One
important role of MMPs is the degradation of the ECM and inter-
estingly in NRTN knockout mice, enhanced collagen deposition is
evident around the airways, although the mechanism is unknown
(Mauffray et al, 2015). Our data suggest that this may be due to the
effect of NRTN on lung macrophage MMP production.
MMPs have fundamental roles in immune cell trafficking to sites
of infection and this is achieved through cleaving transmembrane-
and matrix-embedded proteins, including chemokines, and regu-
lating the activity of cytokines (Sternlicht & Werb, 2001; Overall,
2002). The MMPs we studied have been implicated in the activation
of the pro-inflammatory cytokines TNFα and IL-β and the anti-
inflammatory TGFβ (Gearing et al, 1994; Ito et al, 1996; Schönbeck et
al, 1998; Dallas et al, 2002; Karsdal et al, 2002; Maeda et al, 2002). Pro-
TNFα is cleaved to its active form by MMP1, MMP2, MMP3 and MMP 9
(Gearing et al, 1994), whereas MMP2, MMP3, and MMP9 cleave latent
TGFβ-binding protein-1 to release TGFβ (Dallas et al, 2002; Maeda et
al, 2002) and may also directly activate the latent form of TGFβ
(Karsdal et al, 2002). MMP2, MMP3, and MMP 9 can both positively
and, with the addition of MMP1, negatively regulate the activation of
IL-1β (Ito et al, 1996; Schönbeck et al, 1998). The monocyte che-
moattractant proteins, CCL2 (MCP-1), CCL7 (MCP-3), CCL8 (MCP-2),
and CCL13 (MCP-4), are all regulated by MMPs. MMP2 cleaves CCL7 to
an inactive form (McQuibban et al, 2000), and MMP1 and MMP3
cleave the active forms of CCL2, CCL8, and CCL13 thereby reducing
their chemoattractant activity (McQuibban et al, 2002). Our data add
another level of complexity to the regulation of cytokines and
chemokines by MMPs. We have shown that macrophage RET ex-
pression is tightly controlled and that activation via neurturin
Figure 6. GDNF family expression is enhanced in
macrophages from the lungs of chronic smokers
and lung tumour tissue.
(A, B, C) Relative GFRα2 (A), RET (B), and MMP2 (C) mRNA
expression (2−ΔCT × 104) in macrophages isolated
from the lungs of patients categorised as “controls” (n
= 16) or chronic obstructive pulmonary disease (GFRα2
and RET, n = 18; MMP2, n = 11). (D, E, F) Relative GFRα2
(D), RET (E), and MMP2 (F) mRNA expression in
macrophages isolated from the lungs of patients
categorised as non-smokers (n = 18) or smokers
(GFRα2 and RET, n = 16; MMP2, n = 8). (G, H) Relative
mRNA expression (2−ΔCT × 104) of GFRα2 (G) and RET (H)
in macrophages isolated from lung tumour tissue
and matching healthy margin tissue (n = 4). (A, B, C, D,
E, F) Data information: Data are shown as median ±
interquartile range (A, B, C, D, E, F). (D, F, H) *P < 0.05,
**P < 0.01; Mann–Whitney U test (D, F), Student’s paired
two-tailed t test (H).
Source data are available for this figure.
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enhances MMP2 production and decreases MMP3 production in
TLR3-activated lung macrophages. This may promote the release of
active TGFβ and reduce the chemotactic potential of CCL7 to attract
monocytes to the site of infection. However, with the crossover in
cytokine and chemokine regulation by MMP2 and MMP3, it remains
unclear how the effect of NRTN on the production of MMP2 and
MMP3 by macrophages influences the inflammatory response to an
infection in vivo.
Our knowledge of the roles of individual MMPs is still limited;
however, several studies have implicated specific MMPs in respi-
ratory disease. MMP2 has beneficial effects in a mouse model of
asthma, where this MMP facilitates the resolution of allergic in-
flammation by allowing cells to egress to the lung (Corry et al, 2004).
On the other hand, in the absence of MMP2 and/or MMP9, specific
chemotactic gradients are disrupted and cause retention of cells in
the lung parenchyma and inhibition of their exit via the airways
(Haas & Madri, 1999; Corry et al, 2002; Li et al, 2002; McGuire et al,
2003; Parks, 2003). Conversely, MMP3 has a detrimental role in
mouse models of acute lung injury and pulmonary fibrosis, with
MMP3-deficient mice exhibiting less severe lung injury and
protection from bleomycin-induced fibrosis (Warner et al, 2001;
Yamashita et al, 2011). Although further studies are required to
elucidate the roles of MMPs in respiratory viral infections, it has
been shown in a mouse model of severe influenza infection (IAV)
that MMP9−/− mice exhibited increased survival and were protected
from IAV-induced lung injury (Rojas-Quintero et al, 2018). This
suggests that a reduction in MMP9 expression would be beneficial
in host defence against respiratory viral infections. Interestingly,
induction of MMP9 expression in macrophages of IAV-infected mice
has been shown to be via the TLR7 pathway (Lee et al, 2017). This
may explain why we did not observe an effect of NRTN on MMP9
expression in TLR3-activated macrophages. Although our this study
is limited to in vitro experiments, our data suggest that in vivo the
GDNF family, through the regulation of MMPs, could affect the
activity of cytokines and chemokines, influencing the cells that
infiltrate the airways in response to a viral infection.
When investigating MMP expression at the mRNA and protein
levels in our system, we noted some discrepancies, which highlights
the need to validate expression at both molecular levels. We ob-
served enhanced MMP2 at the mRNA level in IFNβ-stimulated
macrophages by NRTN; however, NRTN with polyI:C stimulation, but
not IFNβ stimulation, enhanced MMP2 protein expression. It is not
clear why we see this difference but suggests that other factors
produced by TLR3 stimulation may be required for the alteration in
MMP expression at the protein level induced by NRTN, which are not
produced by IFNβ stimulation alone. In addition, MMP9 release
from lung macrophages was reduced by IFNβ at the protein level;
however, no differences were observed at the mRNA level. The
disparity in mRNA and protein levels observed may be due to the
different time points analysed or suggests that IFNβ has post-
translational effects on MMP9.
The GDNF family are members of the wider TGFβ superfamily
(Airaksinen & Saarma, 2002) and as such studies have investigated
their anti-inflammatory functions. GFLs modulate T helper 2 (Th2)
cells by decreasing IL-10 production in a RET-dependent manner
(Almeida et al, 2014), NRTN knockout mice develop exaggerated
inflammation to allergens (Mauffray et al, 2015) and addition of
GDNF or NRTN to activated PBMCs reduces TNF protein (Vargas-Leal
et al, 2005). In corroboration, our data demonstrates that in the
setting of a viral infection, NRTN dampens the release of pro-
inflammatory cytokines from human lung-resident macrophages.
Overall, the outcome of GFRα2-NRTN-RET signalling in immune cells
appears to limit excessive inflammation and drive inflammatory
resolution.
Our data suggest that the GDNF family may be important factors
to investigate in airway disease. We observed enhanced GFRα2 and
MMP2 expression in lung macrophages from current smokers.
Whether this impacts on the development of COPD, or exacerba-
tions of the disease, remains to be elucidated. The glial cell line
derived neurotrophic factor family were first characterised as
neuronal growth factors involved in the development of the ner-
vous system, in particular the enteric nervous system (Airaksinen &
Saarma, 2002). RET activation has not been directly linked to MMPs
in nervous system formation; however, MMP2 is involved in the
migration and network formation of enteric neural crest-derived
cells (Anderson, 2010). The production of matrix proteins via RET
activation has been better characterised in the context of cancer
(Mulligan, 2018). Gain-of-function mutations in RET are associated
with familial neuroendocrine tumours and medullary thyroid
cancers (Jhiang, 2000). Deletion of RET in thyroid carcinomas has
been shown to reduce the production of MMP2 and MMP9 (Lian et
al, 2017). However, RET expression by immune cells in cancer has, to
the best of our knowledge, not been previously assessed. MMPs are
known to alter themicroenvironment to aid cancer progression and
metastases (Kessenbrock et al, 2010). Our data suggest that RET
could be up-regulated in tumour macrophages, thereby limiting
inflammation and enhancing MMP2 production within the tumour
microenvironment. RET inhibition may therefore be an attractive
therapeutic target in cancer as an immune modulator irrespective
of the presence of RET-activating mutations.
Figure 7. A novel role for the GDNF family on macrophages in respiratory viral
infection.
TLR activation of airway epithelial cells enhances the production of NRTN, which
binds to constitutively expressed GFRα2 on the surface of lung macrophages (1).
Viral TLR activation on lung macrophages (2) triggers the release of IFNβ (3),
which acts in an autocrine manner and binds to the IFNα/β receptor, IFNAR (4), to
stimulate the production of RET at the mRNA and protein level (5). RET
translocates to the cytoplasm and binds to GFRα2 (6), stimulating the
production of MMP-2 (7) and dampening the pro-inflammatory cytokine
response.
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All epithelial surfaces have a dense network of nociceptors that
enable them to sense noxious substances, cytokines, and patho-
gens (via pathogen-associated molecular patterns). In turn, neu-
ronal factors released from peripheral neurons influence local cell
recruitment, their activation and ultimately the profile of the im-
mune response (for a review, see Talbot et al [2016]). This integrated
system provides a rapid response to threat, which if reliant on the
immune system alone, could take days to mobilize. Although NRTN
redirected macrophage activity without the presence of neurons, in
vivo we have not ruled out that epithelial-derived NRTN may in-
fluence local sensory neurons or that NRTN could be produced by
other cell types, such as glial cells that have now been described in the
lung (Suarez-Mier & Buckwalter, 2015). The data suggest that epithelial
cells may be able to communicate to neurons the type of threat in-
volved and that neurons in turn may direct an appropriate response.
The alteration in cytokine and matrix protein production by the
GFRα2-RET-NRTN complex that we describe provides many avenues
for therapeutic modulation if the goal is to modulate specific MMP
activity or inflammatory cytokine responses from macrophages.
This may have the advantage of releasing the inflammatory po-
tential of airway macrophages so that they are quicker at quelling
an infectious agent. Further studies investigating the GDNF family in
vivo may also elucidate the roles of specific MMPs and determine




Regions of healthy marginal tissue (>6 cm from the cancer) were
identified and dissected by a histopathologist under auspices of
the Manchester Allergy, Respiratory and Thoracic Surgery (Man-
ARTS) Biobank at the University Hospital of South Manchester.
Ethical approval was granted by the National Research Ethics
Service Committee (ref; 15/NW/0409). Participants with a forced
expiratory volume in 1 s/forced vital capacity (FEV1/FVC) of ≥0.70
with no other underlying respiratory disease were categorised as
“healthy.” Participants with COPD were defined by physician di-
agnosis and exhibited an FEV1/FVC < 0.70. Participants were also
categorised based on smoking status and demographics as de-
tailed in Table S1. Human lung macrophages from “healthy” non-
smokers were used for experiments unless otherwise stated. Lung
tumour samples were collected from the Manchester Cancer Re-
search Centre Biobank under the Manchester Cancer Research
Centre Biobank Research Tissue Bank Ethics (ref; 18/NW/0092). All
patients provided written consent for participation in the studies.
Isolation of airway macrophages from human lung resection
samples
Sterile PBS was flushed through resected lung tissue using a 26 G
needle and syringe until the liquid ran clear as described previously
(Dewhurst et al, 2017). Cells were layered onto Ficoll-paque (GE
Healthcare) the leukocyte cell layer collected, washed in sterile PBS
and counted using trypan blue and a haemocytometer. Cells were
plated in complete RPMI media (RPMI 1640, 10% FCS, 100 U/ml
penicillin, and 100 μg/ml streptomycin [all from Sigma-Aldrich])
and incubated for 1 h at 37°C to allow macrophages to adhere. For
RNA and protein extraction cells were plated at 5 × 105 cells/ml in a
12- or 6-well plate, respectively. For imaging, cells were plated at 1.5
× 105 cells/ml on coverslips in a 24-well plate. Cells were washed
three times with sterile PBS, media replaced and stimulated with
polyI:C (10 μg/ml) (InvivoGen), IFNα, IFNβ, IFNγ or IFNλ (all used at 20
ng/ml), or NRTN (100 ng/ml) (all from Peprotech) and incubated for
24 h at 37°C before further processing.
Isolation of macrophages from tumour tissue and matching
healthy margin tissue
Lung and tumour tissue was finely chopped and enzymatically digested
with Liberase TL (0.125 mg/ml; Sigma-Aldrich) and DNase (150 U/ml;
Sigma-Aldrich) in HBSS (Sigma-Aldrich) in a shaking incubator at
37°C for 30 min. Tissue was passed through a 70 μM filter and the
cell suspension centrifuged at 400g for 5 min. Cells were resus-
pended in sterile distilled water for 30 s to lyse red blood cells. Cells
were centrifuged and washed with sterile PBS and counted using
trypan blue and a haemocytometer. Cells were plated at 1.25 × 105
cells/ml in a 24-well plate and incubated for 1 h at 37°C to allow
macrophages to adhere. Cells were washed three times with sterile
PBS and lysed in RLT buffer (QIAGEN) for RNA extraction.
Isolation and culture of MDMs
Leukocyte apheresis cones from healthy donors were provided by
the national blood transfusion service, layered onto Ficoll-paque (GE
Healthcare) and leukocyte cell layer collected. Cellswerewashed in sterile
PBS and counted using trypan blue and a haemocytometer. PBMCs were
incubated with anti-human CD14 magnetic beads (Miltenyi Biotec) and
sterileMACSbuffer (sterile PBS, 0.5%BSA, 2mMEDTA) andpassed through
an LS MACS separation column in a MidiMACS separator according to the
manufacturer’s instructions (Miltenyi Biotec) to obtain purified CD14+
monocytes. CD14+monocyteswereplatedat 0.75 × 106 cells/ml ina 12-well
plate for RNA isolation or a six-well plate for protein extraction and
cultured in complete RPMImediawithM-CSF (50 ng/ml) (Peprotech). Half
of themedia was replaced after 3 d without the addition of M-CSF. After 6
d, media was replaced and differentiated macrophages stimulated with
LPS (100 ng/ml), polyI:C (10 μg/ml), R848 (100 ng/ml) (all from InvivoGen),
IFNγ, IL-4, IL-10, IL-13, IFNα, IFNβ, or IFNλ (all 20ng/mland fromPeprotech)
and incubated for 24 h at 37°C before further processing.
Mouse model of influenza virus infection
8- to 12-wk-old C57BL/6 mice (Harlan Olac Ltd) were kept in specific
pathogen-free conditions at Bio Safety Level 2 with a controlled
temperature (21°C ± 1°C), humidity (55% ± 10%), and a 12-h light/dark
cycle, with food and water ad libitum. All animal procedures were
approved by the Home Office UK and by the University of Manchester
Animal Welfare and Ethical Review Body, and conformed to the re-
quirements of the UK Animals (Scientific Procedures) Act, 1986. Mice
were lightly anaesthetised with isofluorane and infected intranasally
with 7.5 plaque forming units of influenza A virus, Puerto Rico/8/
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34(PR8), H1N1. Mice were euthanized by intraperitoneal injection of 3
mg pentobarbitone at specific time points post-infection. A 21 G needle
attached to a 0.2-mm catheter tube was inserted into the mouse
trachea and 3 × 1 ml of HBSS containing 0.05 M EDTA (Sigma-Aldrich)
was flushed into the lungs to harvest BAL fluid and macrophages as
previously described (Snelgrove et al, 2008).
Isolation and culture of BMDMs
Hind limbs were removed and the bone stripped of skin and
muscle. The tips of the femur and tibia were cut and bone marrow
flushed out with sterile PBS. Cells were centrifuged at 500g for 5
min, supernatant discarded and the pellet resuspended in 3 ml of
red blood cell lysis buffer (Sigma-Aldrich) for 3 min. After centri-
fugation, cells were washed in sterile PBS and resuspended in
complete RPMI media with 20% FCS (Gibco) supplemented with GM-
CSF (20 ng/ml) or M-CSF (20 ng/ml) (both Peprotech) and cultured
for 3 d at 37°C. Media was replaced with complete RPMI media
containing 10% FCS and cells further cultured for 4–7 d until
confluent. Cells were lysed in RLT buffer and stored at −80°C until
RNA extraction.
Cell lines
THP-1 cells were cultured in complete RPMI media and plated at 5 ×
105 cells/ml in a six-well plate or at 2 × 105 cells/ml on fibronectin
coated coverslips in a 24-well plate for imaging. THP-1 cells were
treated with 25 nM phorbol 12-myristate 13-acetate (PMA) (Sigma-
Aldrich) to induce differentiation into macrophages. After 48 h,
fresh complete RPMI medium was added to the cells and the plate
incubated at 37°C overnight before stimulation. The medium was
replaced and THP-1 cells were stimulated with IFNβ (20 ng/ml),
NRTN (100 ng/ml) (both from Peprotech), and/or AD80 (Sell-
eckchem) and incubated for 24 h at 37°C before further processing.
A549 cells were plated at 0.75 × 105 cells/ml in a 12-well plate in
complete DMEM medium and incubated at 37°C overnight before
stimulation. A549 cells were stimulated with polyI:C (10 μg/ml), LPS
(100 ng/ml), R848 (100 ng/ml) (all InvivoGen), or IFNα or IFNβ (both
20 ng/ml and from Peprotech) and incubated for 24 h at 37°C before
further processing.
RNA extraction and qPCR
RNA was isolated using the RNeasy micro kit according to the
manufacturer’s instructions (QIAGEN) and total RNA was quantified
using a NanoDrop spectrophotometer (Thermo Fisher Scientific).
Reverse transcription of equivalent amounts of RNA was carried out
using the High-Capacity RNA-to-cDNA kit according to the manu-
facturer’s instructions (Applied Biosystems). qPCR reactions were
performed using TaqMan Fast Universal PCR master mix and pre-
designed Taqman expression assays (both from Life Technologies)
or SybrGreenmaster mix (Applied Biosystems) on a Quantstudio 12k
flex PCR system (Life Technologies). The RT2 Profiler qPCR array for
mouse neurotrophins and receptors was carried out according to
the manufacturer’s instructions. 1 μg of RNA from each sample was
reverse transcribed using the RT2 First Strand Kit (QIAGEN) and
qPCR reactions were performed using RT2 SybrGreen Rox qPCR
Master Mix. Data were analysed using the SABiosciences RT2 Profiler
qPCR Array Data Analysis version 3.5. The GeneQuery Human
Macrophage Cell Biology qPCR Array Kit was carried out according to
the manufacturer’s instructions. 250 ng cDNA was used in each well
of the 96-well plate provided. Relative mRNA expression was cal-
culated based on the ΔΔCTmethod (Livak & Schmittgen, 2001) using
QuantStudio 12K Flex Software v1.1.1 (Life Technologies).
The average mRNA expressions of the housekeeping genes
RN18s and Hprt were used to calculate relative mRNA levels in
mouse BMDMs and mouse alveolar macrophages. The mRNA ex-
pression of RPLP0 was used to calculate relative mRNA levels in
humanmonocytes, MDMs, BEAS-2B cells, A549 cells, THP-1 cells, and
human lung, tumour, and sputummacrophages. RET9 was detected
using the following primer pair: forward primer – 59TCCCTTCCAC-
ATGGATTG-39; reverse primer – 59-ATCACAGAGAGGAAGGATAGT-39
and RET 51 was detected using the following primer pair: forward
primer – 59-CTCCCTTCCACATGGATTG-39; reverse primer – 59-TCAGCT-
CTCGTGAGTGGT-39. Gene expression was normalised to the house-
keeping gene GAPDH using the following primer pair: forward Primer,
59-GAAGGTGAAGGTCGGAGT-39, reverse Primer, 59-CATGGGTGGAATCA-
TATTGGAA-39.
Protein extraction and Western blot analysis
Human lung macrophages, MDMs and THP-1 macrophages were
lysed in RIPA buffer (50 mM Tris–HCL [pH 7.4], 1% NP-40, 0.25%
Sodium Deoxycholate, 150 mM NaCl, and 1 mM EDTA) with protease
inhibitors (Protease Inhibitor Cocktail; Sigma-Aldrich). Protein
concentrations were determined using a BCA Protein Assay Kit
(Thermo Fisher Scientific). Equivalent amounts of protein (50 μg)
were added to 4× Laemmli sample buffer (2% SDS, 20% glycerol,
0.2% bromophenol blue, 1 M Tris–HCl [pH 6.8]). To detect RET in
MDMs, 4% SDS in 1× laemmli sample buffer was used. Samples were
loaded into 4–20% mini-Protean TGX precast gels (Bio-Rad) and
resolved by electrophoresis and transferred to nitrocellulose
membranes (Bio-Rad) using a semi-dry Trans-Blot turbo transfer
system (Bio-Rad). The membrane was blocked with 5%milk (Sigma-
Aldrich) and 0.1% Tween 20 (Sigma-Aldrich) in PBS for 1 h at room
temperature and incubated overnight at 4°C with antibodies for
GFRα2 (1:500; R&D Systems), RET, MMP1, MMP2, MMP3, and MMP9
and pro-MMP9 (all used at 1:1,000; Cell Signalling Technology).
Membranes were washed three times with 0.1% Tween 20 in PBS for
10 min and anti-rabbit HRP-conjugated secondary antibody
(1:3,000; Dako) diluted in 5% milk and 0.1% Tween 20 in PBS was
added and incubated for 1 h at room temperature on an orbital
shaker. β-actin-peroxidase (1:10,000; Sigma-Aldrich) was used as
the housekeeping control. The membranes were developed using a
Clarity Western ECL Substrate (Bio-Rad) and visualised with a
ChemiDoc MP Imaging System (Bio-Rad).
Immunocytochemistry and immunofluorescence
Cells were fixed in 4% paraformaldehyde for 20 min, washed in PBS,
and lung macrophages incubated in 10% donkey serum in PBS and
THP-1 macrophages incubated in 5% goat serum and 0.3% Triton
X-100 in PBS to for 1 h at room temperature to block non-specific
binding. Blocking buffer was removed and wells incubated with
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GFRα2 (5 μg/ml; normal goat IgG isotype control; R&D Systems) or
RET (2 μg/ml; rabbit mAb IgG XP isotype control; Cell Signalling
Technology) in PBS containing 1% BSA 1% donkey serum or 1% BSA
and 0.3% Triton x-100, respectively, overnight at 4°C. Wells were
washed three times with PBS and lungmacrophages incubated with
donkey antigoat IgG AF647 secondary antibody (1 μg/ml; Invitrogen)
and THP-1 macrophages incubated with goat anti-rabbit IgG AF647
secondary antibody (1:1,000; Cell Signalling Technology) for 1 h at
room temperature. Wells were washed three times with PBS and
coverslips mounted onto slides using Prolong Gold Antifade re-
agent with DAPI overnight at room temperature in the dark. Images
were collected on a Zeiss Axioimager.D2 upright microscope using a
20×/0.5 EC Plan-neofluar objective and captured using a Coolsnap
HQ2 camera (Photometrics) through Micromanager software v1.4.23.
Specific band pass filter sets for DAPI and Cy5 were used to prevent
bleed through from one channel to the next. Images were then
processed and analysed using Fiji ImageJ (http://imagej.net/Fiji/
Downloads).
ELISAs
IL-6, TNFα, IL-12p40, IL-10 (all DuoSet; R&D Systems), mouse NRTN
(Stratech), and human NRTN (Universal Biologicals) were measured in
supernatants, cell lysates, or BAL fluid by enzyme-linked immuno-
sorbent assay (ELISA) according to the manufacturer’s instructions.
Gelatin degradation assay
Matrix degradation by primary lung macrophages was measured
using the QCM Gelatin Invadopodia Assay (EMDMillipore) according
to the manufacturer’s instructions. Lung macrophages were plated
at 1.5 × 105 in Nunc Labtek 8-well chamber slides (Thermo Fisher
Scientific). Cell induced degradation of fluorescent gelatin was
quantified as either the percent of degradation area per cell or the
percentage of degradation area per total cell area. Data are dis-
played as a relative percentage normalised to poly(I:C), with poly(I:C)
set to 100%. Analysis was performed according to manufactures
instructions using Fiji ImageJ (http://imagej.net/Fiji/Downloads).
DAPI and phalloidin signal was thresholded for high intensities, and
then analysed as particles to provide a cell (nuclear) count or
measurement of cell area. For quantification of the area of deg-
radation Cy3-gelatin signal was thresholded for low intensities, then
analysed as particles. Images were obtained using a Leica DM IL LED
inverted microscope using a 4×/0.1 Hi-Plan objective and captured
using a Leica DFC3000 G camera. Specific band pass filter sets for
DAPI, FITC and Texas Red were used to prevent bleed through from
one channel to the next.
Statistics
GraphPad Prism version 7 was used for all statistical analysis. For
multiple dataset analysis of parametric data, ANOVA with Tukey’s
correction was applied. For multiple dataset analysis of non-parametric
data, a Kruskal–Wallis test with Dunn’s multiple comparisons test was
applied. To compare two datasets, an unpaired or paired t test was
applied. Data are presented as the mean ± SD. P-values < 0.05 were
considered significant (*P < 0.05, **P < 0.01, ***P < 0.001).
Supplementary Information
Supplementary Information is available at https://doi.org/10.26508/lsa.
202000780.
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